After achieving clinical validation earlier this year, ReCode Therapeutics has called up a new CEO to take on the mission of ...

As Chinese companies push beyond “me-too” drugs and the country lays out a new five-year plan targeting a $522 billion–strong ...

First patient dosed marks an important step for the SMA community and highlights a growing rare disease manufacturing ...

MCS has recently expanded its Quick Ship Program product line to include over 500 different sizes of precision-ground ...

The Opioid Analgesic REMS is an FDA-required program for opioid analgesics intended for outpatient use. It is designed to ...

(Nasdaq:VOGX), a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal ...

Envoy Medical's global patent portfolio now consists of: 35 pending applications (26 foreign and 9 U.S.) The foreign patent ...

WALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- X-Chem, a global leader in innovative drug discovery services, announced ...

Sjögren's disease is a systemic autoimmune disease that affects the entire body. Along with symptoms of extensive dryness, ...

The care model behind REACH is independently validated by Optum Advisory, delivering $3,607 in total cost savings per treated ...

Teal Health, creators of the Teal Wand™, the first and most accurate FDA-authorized self-collection device for at-home HPV ...

Designation enhances Kedrion's development program for QIVIGY ® and represents an important milestone for patients with Stiff ...